Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments

Yasser Arafat; Matthew Loft; Ke Cao; Fiona Reid; Suzanne Kosmider; Margret Lee; Peter Gibbs; Ian G Faragher; Justin M Yeung

doi:10.1111/ans.18046

Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments

ANZ J Surg. 2022 Nov;92(11):2784-2785. doi: 10.1111/ans.18046.

Authors

Yasser Arafat^{1

2}, Matthew Loft^{2

3}, Ke Cao², Fiona Reid^{1

2}, Suzanne Kosmider³, Margret Lee^{3

4

5}, Peter Gibbs^{2

3

4}, Ian G Faragher^{1

2}, Justin M Yeung^{1

2}

Affiliations

¹ Department of Colorectal Surgery, Western Health, Melbourne, Victoria, Australia.
² Western Precinct, The University of Melbourne, Melbourne, Victoria, Australia.
³ Department of Oncology, Western Health, Melbourne, Victoria, Australia.
⁴ Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
⁵ Consultant Department of Medical Oncology, Eastern Health, Melbourne, Victoria, Australia.

No abstract available

MeSH terms

Colorectal Neoplasms* / drug therapy
Humans